Neuralink’s First Human Implant: Progress Report

In January 2024, Elon Musk’s neurotechnology company, Neuralink, achieved a historic milestone by successfully implanting a brain-computer interface (BCI) into a human patient. This event marked the beginning of the PRIME Study, a clinical trial designed to evaluate the safety and functionality of the device. The goal is ambitious: enabling people with paralysis to control external devices using only their thoughts. Months later, the company has released significant data regarding the patient’s capabilities, the device’s performance, and the unexpected engineering hurdles they have faced.

Meet the First Patient: Noland Arbaugh

The first human to receive the Neuralink implant is Noland Arbaugh, a 29-year-old former medical student from Texas. Arbaugh suffered a diving accident eight years ago that resulted in a spinal cord injury, leaving him with quadriplegia. He is paralyzed from the shoulders down and has no sensation or movement in his hands or legs.

Arbaugh volunteered for the PRIME Study (Precise Robotically Implanted Brain-Computer Interface) to help advance the technology. Before the surgery, he relied on a mouth stick (a stylus held in the mouth) to interact with tablet devices. The surgery was performed at the Barrow Neurological Institute in Phoenix, Arizona, using Neuralink’s proprietary R1 Robot to insert the threads into the motor cortex of his brain.

The Device: "Telepathy" in Action

The specific product implanted in Arbaugh is known as the N1 Implant, although Musk refers to the consumer-facing application as “Telepathy.” The device is roughly the size of a coin and sits flush with the skull. It features 64 ultra-thin threads containing 1,024 electrodes that detect neural activity.

Since the surgery, Arbaugh has demonstrated remarkable control over digital interfaces. His achievements include:

  • Cursor Control: He can move a mouse cursor across a screen with high precision simply by imagining the movement of his hand.
  • Gaming: Arbaugh has successfully played complex video games. He engaged in marathon sessions of Civilization VI, a strategy game that requires complex menu navigation. He also played Mario Kart against a friend, demonstrating the ability to react in real-time.
  • Web Browsing: The implant allows him to browse the internet, read social media, and manage digital communications independently.

Arbaugh described the experience as intuitive. He noted that initially, he would attempt to move his hand physically, but eventually, he learned to just imagine the movement to get the cursor to respond.

Technical Challenges: The Retracting Threads

Despite the initial success, the trial faced a significant hardware complication in the weeks following the surgery. Neuralink engineers observed a decrease in the amount of data being captured by the device.

The company discovered that a number of the microscopic threads had retracted (pulled back) from the brain tissue. This retraction meant that fewer electrodes were in direct contact with the necessary neurons, reducing the “bits-per-second” (BPS) accuracy of the cursor control.

The Software Fix

Rather than performing a risky follow-up surgery to replace the threads, Neuralink addressed the issue through software updates. The engineering team modified the recording algorithm to be more sensitive to neural population signals. They also adjusted how these signals were translated into cursor movements.

According to Neuralink, these software adjustments not only recovered the lost functionality but actually improved Arbaugh’s control beyond his initial performance levels. This demonstrated that the N1 Implant could remain effective even with fewer active electrodes than originally planned.

The Future of the Trial: Patient Two and Beyond

Following the resolution of the thread retraction issue, the Food and Drug Administration (FDA) gave Neuralink the green light to proceed with a second human participant.

For the second surgery, Neuralink plans to make specific adjustments to mitigate the retraction issue. The company intends to implant the threads deeper into the brain tissue. While Arbaugh’s threads were inserted to a depth of roughly 3 to 5 millimeters, the plan for the next patient involves placing them 8 millimeters deep. This creates less tension on the threads and places them closer to the brain’s folds where there may be less movement.

Expanding Capabilities

While the current focus is on cursor control and digital independence, the long-term roadmap for Neuralink is much broader.

  • Mobility: The company aims to bridge the gap between the brain and the spinal cord, potentially allowing patients to bypass injury sites and move their limbs again.
  • Blindsight: Another product in development, often referred to as “Blindsight,” aims to restore visual input for individuals who have lost their sight or were born blind.

Understanding the Competition

Neuralink is not the only player in the Brain-Computer Interface space, though it garners the most media attention. It is important to contextualize their progress against other entities:

  • Synchron: This company has beaten Neuralink to human trials by using a different approach. Their “Stentrode” device is inserted via blood vessels (specifically the jugular vein) rather than through open brain surgery. This is less invasive but may offer lower data bandwidth compared to Neuralink’s direct cortical interface.
  • Blackrock Neurotech: This company has implanted BCIs in dozens of patients over the last two decades. Their Utah Array is a standard in research, though it typically requires a wired connection through the skull, whereas Neuralink is fully wireless.

Safety and Ethical Considerations

The primary focus of the FDA and the medical community remains the long-term safety of the N1 Implant. The brain is a corrosive environment for electronics, and scar tissue (gliosis) can form around electrodes, potentially degrading signal quality over years.

Furthermore, the R1 Robot is a critical component of the safety protocol. Because the threads are thinner than a human hair and the brain moves with every heartbeat and breath, a human surgeon cannot insert them manually. The robot creates the incision, inserts the threads avoiding blood vessels, and closes the site. Validating the robot’s consistency is as important as validating the chip itself.

Frequently Asked Questions

Is the Neuralink implant available to the public? No. The device is currently in the clinical trial phase (PRIME Study). It is only available to a select few participants who meet strict medical criteria, primarily those with quadriplegia or ALS. Widespread commercial availability is likely many years away.

How does the device charge? The N1 Implant uses a wireless battery. The patient wears a small, external induction charger (often integrated into a hat or headpiece) that transfers power through the skin to the device.

Can the patient feel the chip? No. The brain itself has no pain receptors. Once the surgical incision on the scalp heals, the patient does not feel the device inside their skull. Noland Arbaugh has stated he cannot feel the implant.

What happens if the device breaks? This is a key part of the study. Neuralink must demonstrate that the device can be safely removed or upgraded without damaging the brain tissue. The explant procedure is a critical safety metric the FDA is monitoring.

How much does the surgery cost? For the trial participants, the costs are covered by the study. There is no announced retail price for the procedure yet. However, Elon Musk has suggested that eventually, the price aims to be comparable to LASIK eye surgery, though early commercial versions will undoubtedly be expensive medical procedures.